HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors

Radiotherapy and Oncology

Volumn 95, Issue 3, 2010, Pages 365-370

  de Jong, Monique C ^a,b   Pramana, Jimmy ^a,c   Knegjens, Joost L ^b   Balm, Alfons J M ^a,c   van den Brekel, Michiel W M ^a,c   Hauptmann, Michael ^b   Begg, Adrian C ^a   Rasch, Coen R N ^b  

^a

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cisplatin; Gene expression; Head and neck cancer; Human papilloma virus; Prediction; Radiotherapy

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; DRUG MEGADOSE; FEMALE; FOLLOW UP; GENE EXPRESSION PROFILING; HEAD AND NECK CANCER; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARYNX CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; TUMOR VOLUME; WART VIRUS;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; RISK FACTORS;

EID: 77952583995     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.02.001     Document Type: Article

References (37)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Gourin C.G., and Podolsky R.H. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope 116 (2006) 1093-1106
3. Argiris A., Karamouzis M.V., Raben D., and Ferris R.L. Head and neck cancer. Lancet 371 (2008) 1695-1709
4. Seiwert T.Y., Salama J.K., and Vokes E.E. The chemoradiation paradigm in head and neck cancer. Nat Clin Pract Oncol 4 (2007) 156-171
5. Salama J.K., Seiwert T.Y., and Vokes E.E. Chemoradiotherapy for locally advanced head and neck cancer. J Clin Oncol 25 (2007) 4118-4126
6. Browman G.P., Hodson D.I., Mackenzie R.J., Bestic N., and Zuraw L. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 23 (2001) 579-589
7. Pignon J.P., le Maitre A., and Bourhis J. Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69 (2007) S112-S114
8. Bourhis J., le Maitre A., Baujat B., Audry H., and Pignon J.P. Individual patients' data meta-analyses in head and neck cancer. Curr Opin Oncol 19 (2007) 188-194
9. Budach W., Hehr T., Budach V., Belka C., and Dietz K. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6 (2006) 28
10. Doweck I., Denys D., and Robbins K.T. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Laryngoscope 112 (2002) 1742-1749
11. Robbins K.T., Doweck I., Samant S., Vieira F., and Kumar P. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT). Laryngoscope 114 (2004) 411-417
12. Mendenhall W.M., Morris C.G., Amdur R.J., Hinerman R.W., and Mancuso A.A. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 25 (2003) 535-542
13. Prosnitz R.G., Yao B., Farrell C.L., Clough R., and Brizel D.M. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1087-1095
14. Chufal K.S., Rastogi M., Srivastava M., Pant M.C., Bhatt M.L., and Srivastava K. Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume. Jpn J Clin Oncol 36 (2006) 537-546
15. Rudat V., Dietz A., Schramm O., et al. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol 53 (1999) 119-125
16. Sanguineti G., Corvo R., Sormani M.P., et al. Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome. Int J Radiat Oncol Biol Phys 44 (1999) 139-147
17. Doweck I., Robbins K.T., and Vieira F. Analysis of risk factors predictive of distant failure after targeted chemoradiation for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 127 (2001) 1315-1318
18. Denys D., Kumar P., Wong F.S., Newman L.A., and Robbins K.T. The predictive value of tumor regression rates during chemoradiation therapy in patients with advanced head and neck squamous cell carcinoma. Am J Surg 174 (1997) 561-564
19. Gasparini G., Bevilacqua P., Bonoldi E., et al. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Clin Cancer Res 1 (1995) 1375-1383
20. Knegjens J.L., Pameijer F.A., Balm A.J.M., Hauptmann M., Hoebers F.J., and Rasch C.R.N. Tumor volume as outcome predictor in chemoradiation for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) S410-S411 (accepted for publication in Head and Neck)
21. Chen S.W., Yang S.N., Liang J.A., Lin F.J., and Tsai M.H. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy. Head Neck (2009)
22. Klussmann J.P., Mooren J.J., Lehnen M., et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15 (2009) 1779-1786
23. Lassen P., Eriksen J.G., Hamilton-Dutoit S., Tramm T., Alsner J., and Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 27 (2009) 1992-1998
24. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 (2008) 261-269
25. Ragin C.C., and Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 121 (2007) 1813-1820
26. Weinberger P.M., Yu Z., Haffty B.G., et al. Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24 (2006) 736-747
27. Dumur C.I., Ladd A.C., Wright H.V., et al. Genes involved in radiation therapy response in head and neck cancers. Laryngoscope 119 (2009) 91-101
28. Ginos M.A., Page G.P., Michalowicz B.S., et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 64 (2004) 55-63
29. Ganly I., Talbot S., Carlson D., et al. Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma. J Clin Oncol 25 (2007) 1369-1376
30. Chung C.H., Parker J.S., Karaca G., et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5 (2004) 489-500
31. Chung C.H., Parker J.S., Ely K., et al. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res 66 (2006) 8210-8218
32. Pramana J., Van den Brekel M.W., van Velthuysen M.L., et al. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1544-1552
33. Slebos R.J., Yi Y., Ely K., et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 12 (2006) 701-709
34. www.oncoline.nl.
35. Rasch CR, Balm AJ, Kroger R, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a phase III trial. Cancer, 2010; doi:10.1002/cncr.24916.
36. van den Broek G.B., Wildeman M., Rasch C.R., et al. Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation. Int J Cancer 124 (2009) 2643-2650
37. Lassen P., Eriksen J.G., Hamilton-Dutoit S., Tramm T., Alsner J., and Overgaard J. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol 94 (2010) 30-35